Back to search

Article

Shallow nanopore RNA sequencing enables transcriptome profiling for precision cancer medicine

2022-05-31

Abstract excerpt

<h4>ABSTRACT</h4> Transcriptome profiling is a mainstay of translational cancer research and is increasingly finding its way into precision oncology. While bulk RNA sequencing (RNA-seq) is widely available, high costs and long data return time are limiting factors for clinical applications. We investigated a portable nanopore long-read sequencing device (MinION, Oxford Nanopore Technologies) for transcriptome pro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c6617344-0852-5eb7-aed2-bfdb47b66268
DOI
10.1101/2022.05.31.494109
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Shallow nanopore RNA sequencing enables transcriptome profiling for precision cancer medicineDOI 10.1101/2022.05.31.494109
Select a neighboring publication to make it the new centre.